Civeo Stock Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Civeo in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Civeo stock.
View analyst ratings for Civeo or view top-rated stocks.

Wall Street analysts have given Civeo a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Civeo wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Civeo saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 60,700 shares, an increase of 24.4% from the June 30th total of 48,800 shares. Based on an average daily volume of 36,800 shares, the days-to-cover ratio is currently 1.6 days. Approximately 0.5% of the shares of the stock are sold short.
View Civeo's Short Interest.

Civeo is scheduled to release its next quarterly earnings announcement on Friday, July 30th 2021.
View our earnings forecast for Civeo.

Civeo will be holding an earnings conference call on Friday, July 30th at 11:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "8892853#".

Civeo Co. (NYSE:CVEO) released its quarterly earnings results on Thursday, April, 29th. The business services provider reported ($0.70) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.56) by $0.14. The business services provider had revenue of $125.43 million for the quarter, compared to the consensus estimate of $125.30 million. Civeo had a net margin of 0.45% and a trailing twelve-month return on equity of 2.37%.
View Civeo's earnings history.

Civeo's stock was trading at $9.0372 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CVEO stock has increased by 142.3% and is now trading at $21.90.
View which stocks have been most impacted by COVID-19.

Shares of Civeo reverse split on Friday, November 20th 2020. The 1-12 reverse split was announced on Monday, November 9th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, November 19th 2020. An investor that had 100 shares of Civeo stock prior to the reverse split would have 8 shares after the split.

Civeo updated its FY 2021 earnings guidance on Friday, May, 7th. The company provided earnings per share guidance of - for the period. The company issued revenue guidance of $555 million-$580 million, compared to the consensus revenue estimate of $557.90 million.

2 equities research analysts have issued 1 year target prices for Civeo's stock. Their forecasts range from $2.50 to $9.60. On average, they anticipate Civeo's share price to reach $6.05 in the next year. This suggests that the stock has a possible downside of 72.4%.
View analysts' price targets for Civeo or view top-rated stocks among Wall Street analysts.

15 employees have rated Civeo CEO Bradley J. Dodson on Glassdoor.com. Bradley J. Dodson has an approval rating of 75% among Civeo's employees.

Some companies that are related to Civeo include Monarch Casino & Resort (MCRI), Johnson Outdoors (JOUT), Smith & Wesson Brands (SWBI), Playa Hotels & Resorts (PLYA), PLBY Group (PLBY), Flight Centre Travel Group (FGETF), Smart Share Global (EM), Studio City International (MSC), Accel Entertainment (ACEL), NeoGames (NGMS), Party City Holdco (PRTY), IMAX (IMAX), The Aaron's (AAN), GreenTree Hospitality Group (GHG) and Corus Entertainment (CJREF).
View all of CVEO's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Civeo investors own include Novavax (NVAX), Co-Diagnostics (CODX), Livongo Health (LVGO), NVIDIA (NVDA), Alto Ingredients (PEIX), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Maxar Technologies (MAXR), Marvell Technology (MRVL) and The Boeing (BA).

Civeo trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVEO."

Civeo's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include TCW Group Inc. (1.48%). Company insiders that own Civeo stock include Allan Schoening, Bradley J Dodson, Lance Torgerson, Martin Lambert and Peter Mccann.
View institutional ownership trends for Civeo.

CVEO stock was purchased by a variety of institutional investors in the last quarter, including TCW Group Inc.. Company insiders that have bought Civeo stock in the last two years include Bradley J Dodson, and Martin Lambert.
View insider buying and selling activity for Civeo or or view top insider-buying stocks.

Shares of CVEO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CVEO stock can currently be purchased for approximately $21.90.

Civeo has a market capitalization of $313.02 million and generates $529.73 million in revenue each year. The business services provider earns $-134,250,000.00 in net income (profit) each year or $0.89 on an earnings per share basis.

Civeo employs 2,000 workers across the globe.

The official website for Civeo is www.civeo.com.

Civeo is headquartered at THREE ALLEN CENTER 333 CLAY STREET SUITE 4980, HOUSTON TX, 77002.

Civeo's mailing address is THREE ALLEN CENTER 333 CLAY STREET SUITE 4980, HOUSTON TX, 77002. The business services provider can be reached via phone at 713-510-2400 or via email at [email protected]